AGCO: 21 Times Trough Earnings for a Maker Whose Europe Supplies Two Thirds of Sales While PTx Must Compound 23.5% to Reach $2bn by 2029

That distinction matters for 2027. AGCO deliberately underproduced demand in 2025: excluding Grain & Protein, production hours fell roughly 12% while unit sales fell about 6%. That is what a manufacturer does when it wants to drain dealer inventory. Management expects 2026 production hours to sit slightly below 2025 again. Once Latin American and North American inventories reach target, production can rise faster than retail demand, producing a classic restocking earnings tailwind. Europe is different. Its inventories are already lean, so a European recovery requires the farmer to come back.

The structural claim starts with PTx. AGCO says PTx generated about $860 million of revenue in 2025 and continues to target approximately $2 billion by 2029. Getting from $860 million to $2 billion in four years requires a 23.5% compound annual growth rate. In July, management said 2026 PTx sales were likely to be flat to only modestly higher, which makes the remaining climb substantially steeper: a 2026 base near $0.9 billion would require around 30% annual growth in 2027–29 to reach $2 billion.

There are good reasons to take PTx seriously. The technology is sold through three routes: AGCO factory installation, more than 100 third-party OEM relationships, and retrofit sales to existing mixed-brand fleets. AGCO had about 320 PTx dealers by mid-2026, including 85 “Elite” dealers, and management said more than 90% of its target market was covered by some form of PTx dealer. SymphonyVision targeted spraying was sold out for the 2026 season and expected to grow more than 30%, while management argues many retrofit products offer one-to-two-year farmer paybacks.

There are equally important reasons not to value PTx like software. AGCO's 2025 annual report says that precision-technology services and subscriptions exist, but associated subscription revenue is not significant; substantially all product revenue is recognized at a point in time. The company does not disclose a PTx operating margin or the precise split between AGCO factory-fit, third-party OEM and retrofit revenue. And AGCO recorded an approximately $351 million goodwill impairment associated with PTx Trimble in 2024, less than a year after closing the transaction. Those facts make the current PTx story a high-margin hardware-and-technology growth thesis, not a proven recurring-software annuity.

The competitive logic still makes sense. Deere can afford a more vertically integrated, Deere-centric technology stack because it controls a much larger installed base. AGCO starts from a smaller machine population. Its rational response is to make PTx work on Deere, CNH and other machines as well as its own. Openness expands AGCO's addressable market; Deere's integration can deliver tighter machine-data-service economics. The test is whether AGCO's interoperability eventually creates recurring economics and durable customer ownership rather than merely selling useful hardware onto competitors' fleets.

Replacement parts are the less glamorous but more proven leg of the transformation. Parts generated $1.87 billion in 2025, 19% of total sales, up from 13% of the mix in 2023. Management has set a roughly $2.3 billion 2029 objective, which requires only about 5.3% annual growth from the 2025 base. Far less heroic than PTx. Parts demand tracks the installed machine population, not new-equipment orders, and AGCO has been adding distribution capacity and digital ordering.

Portfolio repair is already visible. AGCO agreed in July 2024 to sell most of Grain & Protein to American Industrial Partners for $700 million; the transaction closed that November. Net cash proceeds were about $631 million, and the divested business contributed $816.5 million of 2024 revenue. The divestiture removed GSI, AP, Cumberland, Cimbria and Tecno while retaining the China Grain & Protein operation. By 2025 residual Grain & Protein sales were immaterial. The sale reduced reported scale but improved the strategic concentration on machinery, parts and precision agriculture.

TAFE created a second portfolio reset. AGCO sold its 20.7% TAFE stake back to TAFE in September 2025 for $260 million, approximately $230 million after tax, after transferring ownership of the Massey Ferguson brand in India, Nepal and Bhutan under the June 2025 settlement. That ended a long and increasingly adversarial commercial relationship. TAFE remains AGCO's largest shareholder and a direct machinery competitor.

One factual point in the assignment brief needs correction. The brief asks for the expiry of TAFE's standstill. AGCO's 2026 proxy says the relevant standstill provisions do not expire. TAFE can instead be released from portions of the restrictions under specified extraordinary-event conditions, such as a company sale process, certain tender offers or another holder crossing defined ownership thresholds. I treat the standstill as indefinite, not as an agreement with a scheduled expiry date.

At $119.79, AGCO is an odd-looking stock if one values the wrong earnings year. The midpoint of 2026 adjusted EPS guidance is $5.625, putting the shares at about 21.3 times trough adjusted EPS. That is not statistically “cheap.” A normalized cycle tells a different story. If demand returns from roughly 85% of mid-cycle, parts continue growing, and AGCO can produce an 11–12.5% through-cycle margin, normalized EPS can plausibly reach roughly $11–13 before giving full credit to the 14–15% margin ambition. On that basis the stock is around 9–11 times normalized earnings. The market is already paying for a recovery, but it is not paying for the full 2029 transformation.

The central disagreement is therefore whether AGCO's earnings floor has structurally risen or whether today's apparently cheap normalized multiple simply capitalizes another conventional machinery upcycle. The strongest evidence for structural improvement is the parts mix, Grain & Protein exit, dealer-service redesign, Fendt expansion and a cost base management says has been reduced materially. The weakest evidence is the technology multiple: PTx is growing from a meaningful base, but 2026 is not showing anything close to the growth required for $2 billion in 2029, and recurring revenue remains insignificant.

My qualitative portrait is company in transition. AGCO is not distressed: its 2025 free cash flow was a record $740 million, it is repurchasing shares aggressively, and the balance sheet remains financeable. It is also not yet a high-quality compounder. Earnings remain tightly tied to farmer economics, Europe generates a disproportionate share of profits, and management still has to prove that precision agriculture changes the economics of the enterprise rather than simply changing the product catalogue.

Vertical company history and financial review

AGCO's origin explains much of its present character. The company emerged in 1990 from the North American Deutz-Allis agricultural-equipment operation, then used acquisitions to assemble brands that already had deep agricultural histories and dealer relationships. It was incorporated in Delaware in 1991 and went public in New York in 1992. Deere largely grew around a single dominant corporate identity; AGCO became a federation of agricultural brands instead. That remains both an advantage and an organizational burden.

The first stage, from 1990 through the early 2000s, was an acquisition-led attempt to create global scale. Massey Ferguson gave AGCO a global tractor franchise and enormous brand recognition; Fendt added premium German engineering and eventually became AGCO's most important profitability engine. Valtra brought Nordic and Latin American strength, and Challenger, acquired from Caterpillar's agricultural activities, widened the high-horsepower offering. The logic was straightforward. Agricultural machinery rewards installed base, dealer density, engineering scale and spare-parts availability, so a small stand-alone producer carries structural disadvantages. AGCO bought those assets instead of spending decades building them organically, and the company history and present 10-K show the legacy of that strategy in today's Massey Ferguson, Fendt and Valtra franchises.

The second stage was diversification and industrialization. By the 2010s AGCO was no longer merely a tractor consolidator. It invested heavily in global manufacturing, expanded Fendt beyond tractors, and acquired GSI, moving into grain storage and protein-production equipment. Diversification provided revenue outside the tractor cycle, but it also handed management a collection of businesses with different economics. The later Grain & Protein sale is evidence that management ultimately concluded the diversification discount and capital demands outweighed the benefits.

The third stage began with precision agriculture. AGCO bought Precision Planting in 2017 after Deere's attempted acquisition of that business failed on antitrust grounds. Precision Planting gave AGCO retrofit technology, relationships with farmers who operated competitors' equipment, and an engineering culture that was unusually independent of the OEM into which it was being absorbed. This was the seed of today's PTx strategy: AGCO would compete with Deere in technology without requiring the farmer first to own an AGCO tractor or planter.

The 2020–23 agricultural upcycle then provided the cash and earnings to accelerate that strategy. Farm incomes, commodity prices and equipment replacement demand rose after the pandemic disruption, while manufacturers enjoyed unusually strong pricing. AGCO's revenue reached $14.41 billion in 2023 and adjusted operating margin reached about 12%. Earnings expanded far faster than the pre-2020 baseline. The market began treating AGCO as more than a low-margin machinery roll-up, particularly as Fendt expanded in the Americas and Precision Planting gained visibility.

The fourth stage began almost exactly when the cycle turned down. On April 1, 2024 AGCO and Trimble created PTx Trimble. Trimble contributed most of its agriculture business, while AGCO contributed JCA Technologies and cash; AGCO paid Trimble roughly $1.95 billion and owns 85% of the venture, with Trimble retaining 15%. AGCO consolidates the business and recognizes Trimble's share through non-controlling interest. Trimble's own filing provides a useful independent check on the continuing 15% economic interest.

That timing was painful. AGCO financed the transaction partly by issuing $400 million of 5.45% notes due 2027 and $700 million of 5.8% notes due 2034. As farm-equipment demand weakened, AGCO impaired about $351 million of PTx Trimble goodwill during 2024. The impairment was non-cash, but it is economically relevant: management paid a technology-cycle acquisition price just before agriculture entered a sharp equipment downturn, and the carrying value proved too optimistic almost immediately.

Management responded by narrowing the portfolio. The Grain & Protein sale removed approximately $816.5 million of 2024 revenue and generated about $631 million of net cash proceeds, while also producing a large accounting disposal loss. AGCO used proceeds in part to address the balance sheet after PTx. The result is a cleaner agricultural-equipment exposure but a historical-series break: 2024 included most of a business that 2025 almost entirely lacked. Reported 2025 sales overstate the depth of organic contraction unless Grain & Protein is excluded.

The TAFE settlement in 2025 was the other major break with AGCO's past. AGCO gave up ownership of the Massey Ferguson name in India, Nepal and Bhutan, sold its 20.7% TAFE equity investment for $260 million, and ended the historic commercial arrangement. AGCO recorded a roughly $252 million pretax gain on the sale. This turned an illiquid strategic holding into cash but also ended the company's direct legacy-brand route into a huge tractor market. The transfer does not legally bar Fendt, Valtra or PTx from India, but future Indian expansion would have to use a different brand/channel architecture from the Massey Ferguson relationship that AGCO spent decades relying on.

TAFE's shareholder role is equally unusual. The 2026 proxy reported 12.15 million AGCO shares, 16.8% of the company on the proxy measurement date. The cooperation agreement limits further purchases, obliges TAFE to vote in line with board recommendations on covered matters, prevents renewed public activism and permits pro-rata participation in AGCO repurchases so TAFE can broadly maintain its percentage. For current management that combination is stabilizing, because a large formerly activist shareholder is contractually constrained. It is also a governance oddity, because the largest shareholder is a competitor that now owns the Massey Ferguson brand in India.

AGCO's capital-market history maps closely onto this business history. During weak farm cycles, investors have generally treated the company as a leveraged earnings cyclical and focused on dealer inventory, crop prices and incremental margins. During 2021–23, strong industry pricing, record earnings and the Fendt/precision narrative allowed the market to contemplate a better through-cycle business. The 2024–25 de-rating reflected both collapsing equipment earnings and skepticism over whether the large PTx investment had been made too close to a cyclical peak. By September 2026 the stock had recovered to $119.79, which suggests investors no longer price an indefinite trough but have not capitalized AGCO like a technology compounder.

I do not assign a precise historical P/E percentile. A mechanically calculated trough P/E is a poor tool for an equipment manufacturer, because the denominator is smallest near the point at which the stock should begin discounting recovery. The current 21.3 times midpoint 2026 adjusted EPS looks expensive against trough profit; the 9–11 times multiple on a reasonable normalized earnings estimate looks much more ordinary. The valuation center has shifted somewhat upward because AGCO now owns more parts and precision-agriculture earnings, but the evidence does not support a software-like multiple.

The longer financial record shows the cycle clearly.

Company filings and earnings releases; 2026 cash flow is seasonal and H1 should not be annualized mechanically.

The rise through 2023 was not pure volume growth. Pricing and mix were important, as agricultural-equipment manufacturers passed supply-chain inflation through to customers and farmers could absorb it because crop economics were strong. The reverse has been similarly nonlinear: lower production absorbs fewer factory fixed costs, dealers require incentives to clear aged inventory, and high-margin large equipment is disproportionately exposed. That is why a roughly 30% revenue decline from the 2023 peak to 2025 translated into a much larger fall in adjusted EPS.

Cash flow has been better than the income statement during parts of the downturn, but 2025 needs interpretation. Free cash flow reached a record $740 million even while adjusted EPS fell to $5.28, principally because production cuts and inventory discipline released working capital. Good execution. A working-capital liquidation cannot repeat indefinitely, though, and the first half of 2026 showed the mirror image: operating cash flow was negative $245 million and free cash flow negative roughly $347 million as receivables and inventory absorbed cash. Management still targeted full-year FCF equal to about 75–100% of adjusted net income, implying a strong second-half seasonal recovery.

Over a multi-year period the cash-conversion picture is acceptable rather than exceptional. Using reported operating cash flow and adjusted earnings across the recent cycle, aggregate cash generation is roughly around adjusted net income, with individual years moving violently as dealer inventories and factory production change. That is exactly what one expects from a working-capital-intensive machinery manufacturer. The business does not require permanently rising capital expenditure to generate earnings, but an investor cannot treat every dollar of trough-year inventory release as recurring owner earnings.

The balance sheet has absorbed the cost of PTx. At June 30, 2026 AGCO had approximately $573 million of cash, $547 million of current borrowings and $2.18 billion of long-term debt, for roughly $2.15 billion of net debt. It also carried about $167 million of pension and post-retirement obligations, approximately $292 million of redeemable non-controlling interest, $1.88 billion of goodwill and $645 million of intangible assets. Equity-accounted affiliate investments were about $491 million. On the $8.39 billion equity value derived from the filing share count and September 18 close, an adjusted enterprise value including net debt, pension obligations and redeemable non-controlling interest is roughly $11.0 billion.

Finance needs separate treatment. AGCO has historically partnered with Rabobank in retail and wholesale finance joint ventures instead of consolidating a large captive lender like Deere. Management has said the JVs operate in markets representing about half of AGCO tractor and combine retail sales. In April 2026 AGCO sold its 49% interests in the U.S. and Canadian AGCO Finance ventures for about $190 million, monetizing part of future equity income; other Rabobank partnerships remain. This makes AGCO's industrial balance sheet easier to read than Deere's consolidated financing structure, but also means AGCO gives up some finance profit and customer-data control.

Returns on capital have moved in two directions at once. The operating cycle drove peak returns very high in 2022–23, while the PTx purchase increased invested capital just before earnings fell. A rough adjusted NOPAT-to-invested-capital calculation puts current trough returns around the high-single-digit/low-double-digit area versus well above that at the 2023 peak. The exact number depends heavily on whether acquisition goodwill and the finance-JV stakes are included. What matters more is the trajectory: PTx must eventually earn enough to justify almost $2 billion of cash paid to Trimble plus AGCO's contributed assets. A 2024 goodwill impairment raised that hurdle rather than removing it.

Share repurchases are now materially affecting per-share analysis. Shares outstanding fell from roughly 74.6 million around the third quarter of 2025 to 70.03 million at the July 2026 10-Q cover date, a 6.1% endpoint reduction. With unchanged aggregate earnings, that alone produces approximately 6.5% higher EPS once fully reflected in weighted-average shares. So it matters that 2026 adjusted EPS guidance of $5.50–5.75 is only modestly above 2025's $5.28: part of the per-share improvement is financial engineering, not underlying profit growth. AGCO repurchased roughly $347 million of shares in the first half of 2026 after authorizing a $1 billion program in 2025.

Capital allocation has nonetheless been broadly coherent with the priorities management stated when it sold Grain & Protein: repay debt, fund precision and organic growth, then return excess capital. AGCO took on debt to fund PTx, used portfolio-sale proceeds to repair the balance sheet, sold the TAFE stake for cash, and accelerated repurchases into a depressed machinery cycle. The unresolved question is whether the original PTx purchase price was disciplined. The rapid goodwill impairment prevents a clean “excellent capital allocator” judgment.

Business model, moat, industry and competitors

AGCO's reported segments are geographic, not brand-based, which matters because the economics are highly unequal. In 2025 Europe and the Middle East generated about 67% of group revenue and nearly all of the group's geographic segment profit after losses elsewhere. North America represented only about $1.67 billion of sales, despite being the market investors often instinctively associate with tractors. South America contributed $1.12 billion and Asia-Pacific/Africa about $564 million.

That table exposes AGCO's core economic asymmetry. In a downturn, Europe is the source of virtually all geographic operating profit, and not merely AGCO's largest revenue territory.

Product mix tells a second story. Tractors generated roughly 66% of 2025 sales. Replacement parts were 19%, while combines, application equipment, hay and forage, implements, planters and precision products made up most of the remainder. This makes AGCO much more tractor-centric than Deere. Combines are strategically important to a full-line large-farm proposition, but management itself has acknowledged that AGCO remains a comparatively small combine player.

AGCO's revenue model is wholesale: it generally records equipment revenue when machines are sold to independent dealers or distributors, not when the farmer subsequently buys the machine. The network comprises roughly 2,800 independent dealers and distributors serving approximately 140 countries. That accounting model explains why dealer inventory deserves equal billing with retail demand: AGCO can report strong factory shipments while retail weakens, but doing so merely borrows revenue from the future and leaves dealers overstocked.

Materials, purchased components, freight and production labor are the largest variable costs. Harder to flex are engineering, factory infrastructure, tooling, dealer support and the manufacturing overhead embedded in plants such as Fendt's German footprint. Engineering expense was running near 5% of sales in 2026. Management's restructuring program, launched as the downturn became clear in 2024, is intended to take as much as roughly $200 million out of the cost base, with $60–70 million of incremental operational benefit expected during 2026.

That operating leverage works brutally in both directions. Lower production means fewer machines over which to spread factory depreciation, salaried labor and engineering. A recovery does the reverse. AGCO's decision to cut production hours much faster than retail demand in 2025 depressed near-term margins but accelerates inventory normalization. Once dealers no longer need to destock, a given increase in retail demand can create a larger percentage increase in factory production and operating profit.

The first real moat is Fendt. AGCO does not publish Fendt margins, so calling it the exact “margin engine” is an inference, not a disclosed brand P&L. The evidence behind it is strong all the same: Fendt has premium positioning, AGCO's best profitability sits in Europe, and management continues to prioritize Fendt expansion in North and South America. AGCO has targeted roughly $1.7 billion of Fendt revenue in the Americas by 2029 and says dealer coverage there has expanded markedly over the past five years.

Fendt's moat is engineering plus brand plus channel, not pure technological lock-in. A farmer paying for a high-horsepower Fendt is buying fuel efficiency, transmission performance, uptime, operator preference and local dealer service. Deere can compete head-on; Case IH and New Holland can as well. The moat shows up as sustained willingness to pay and dealer pull, not an inability to switch.

The second moat is the installed base and parts channel. A farmer can postpone a new tractor for a year or two but cannot indefinitely postpone repairing the tractor already planting or harvesting a crop. AGCO's $1.87 billion parts franchise monetizes decades of Massey Ferguson, Fendt and Valtra equipment in the field. The company is expanding distribution centers and e-commerce; management has said digital parts orders tend to carry larger baskets. Parts mix rising from roughly 13% of sales in 2023 to 19% in 2025 reflects both cyclical resilience and deliberate strategy.

The third moat is channel density and service quality. FarmerCore is AGCO's attempt to move dealer capabilities closer to farms, instead of depending solely on a conventional dealership footprint. Management said North American on-farm service capacity had expanded as much as 65%, and dealers furthest along in FarmerCore were generating around 4.5 points better net-promoter scores and roughly 1.5 points of share improvement. Those are management measurements, not audited KPIs. They are still directionally important, because farm-equipment market share is won as much through uptime support as through brochure specifications.

PTx is a potential moat, not a fully proven one. Its mixed-fleet nature attacks the weakest point of OEM ecosystems: farmers frequently own machines from several brands, and replacing an entire fleet merely to adopt one precision system is expensive. AGCO can sell Precision Planting or PTx Trimble technology without first displacing Deere's tractor. That is a genuine distribution advantage. Yet hardware interoperability is easier to copy than a deeply embedded data network, and the 10-K's statement that subscription revenue is not significant means PTx does not yet exhibit the recurring revenue or switching costs that normally justify a technology valuation premium.

The strongest moat conclusion is narrower than management's transformation narrative: AGCO has proven moats in premium machinery, installed-base parts and dealer relationships; the PTx moat is promising but has not yet proven recurring economics.

Management under CEO Eric Hansotia has made unusually large strategic decisions during one cycle: acquire PTx Trimble, sell Grain & Protein, settle TAFE, shrink the cost base, reform the dealer model and repurchase a significant portion of the company. The portfolio is cleaner as a result. The execution record is mixed rather than poor. Record 2025 cash flow and rapid inventory cuts count positively; the PTx impairment and the fact that the flagship $2 billion target now requires accelerating sharply after a flat 2026 count negatively. AGCO's 2026 proxy and annual filings did not reveal a material auditor-resignation or accounting-fraud issue; the accounting challenge is instead the volume of legitimate but large adjustments created by disposals, restructuring and acquisition accounting.

Agricultural machinery is a mature industry in North America and Western Europe. Growth there comes mainly from replacement cycles, price/mix, farm consolidation and richer technology content, not a continuously rising machine count. Emerging economies provide more structural mechanization potential, but farmer credit availability and government programs often dominate near-term purchasing. New entrants face unusually high barriers, because a tractor or combine needs decades of parts availability, local technicians, residual-value confidence and seasonal uptime support. That makes the industry an oligopoly even though product technology is changing.

AGCO experiences several cycles simultaneously: commodity prices affect farmer revenue; fertilizer, diesel, labor and seed determine the margin farmers keep; interest rates and bank standards determine whether they can finance equipment; dealer inventories create a separate wholesale cycle; government support programs influence Brazil and other markets; and technology adoption can either pull purchases forward or shift spending from machines into retrofit kits. The result is a capex cycle sitting on top of an agricultural commodity cycle.

Management's estimate that current global equipment demand is about 85% of historical mid-cycle provides a useful anchor. For 2026 it expected North American large-ag industry demand down about 15%, Western Europe approximately flat and Brazil down around 5–10%, while smaller North American agriculture was expected to decline less sharply. Those assumptions were more cautious than at the start of 2026, because Western Europe and Brazil weakened.

Farm economics remain the demand function. USDA's 2026 farm-income work continued to show heavy reliance on government payments, while an earlier 2026 forecast put U.S. net farm income at about $153 billion and federal government payments at more than $44 billion. USDA's August 2026 WASDE put the 2026/27 U.S. soybean farm price near $11.40 per bushel. Those numbers are less important individually than the combination AGCO describes: low crop profitability, double-digit pressure in some input costs, expensive credit and little urgency for farmers to replace serviceable machines.

I do not fill the report with unsupported spot corn and wheat quotations merely to complete a checklist. The research run did not yield a clean same-date primary table for all three crops before the source window closed. The investment conclusion instead uses company retail-demand data and USDA farm economics. This is one of the report's explicit data blind spots, not a fabricated input.

Europe adds weather and policy. Copernicus reported exceptionally hot conditions and soil-moisture stress across parts of Western Europe during summer 2026. AGCO cited drought, high input costs, regulatory uncertainty and cautious farmer spending when cutting its Western European outlook. France and Germany matter disproportionately, because together they represented nearly 30% of AGCO's 2025 sales.

Brazil adds financing. Management said subsidized government credit programs started later than normal in 2026, while commercial credit remained restrictive and farm production costs were high. These conditions hit machinery demand even when long-term agricultural acreage economics remain attractive. AGCO responded by cutting Latin American production hours by roughly 30% in Q2 to clear aged inventories.

Trade policy is now another real cost line. AGCO estimated 2026 gross tariff costs at about $115 million, partly offset by approximately $22 million of expected IEEPA-related refunds, leaving a net tariff impact close to $95 million and roughly $50 million worse year over year. With an adjusted operating profit run rate below $800 million, that is large enough to move group margin materially.

AGCO competes in a “few large competitors” market, with Deere and CNH the most relevant listed comparisons, Kubota important for compact tractors and Asia, and Claas important in European harvesting despite being private.

Deere became the industry's integrated platform. It combines an enormous installed machine base, high-horsepower agriculture, combines, precision technology, construction machinery and a captive finance arm. Its closed or semi-closed digital architecture is economically logical because Deere can monetize its own installed fleet. Deere's latest 2026 results still showed the agricultural downturn: Production & Precision Agriculture sales fell even as construction and smaller agriculture provided diversification. So Deere gives investors less pure agricultural-cycle exposure than AGCO.

AGCO is the opposite bet. It has no major construction segment to cushion a farm downturn and no consolidated finance engine of Deere's scale. The result is higher direct sensitivity to tractors, crop economics and dealer restocking. In exchange, an investor gets a purer recovery exposure and a technology strategy that can sell onto competitors' installed bases. That purity is valuable when agriculture turns up and painful when Europe turns down.

CNH is the closest structural public comparison. Case IH and New Holland compete across tractors, combines and application equipment, while Raven provides a precision-agriculture technology path. CNH's 2026 commentary also pointed to dealer-inventory stabilization and improving pricing, illustrating that AGCO is not alone in approaching the end of channel destocking. CNH's broader brand scale and combine position are advantages; AGCO's Fendt premium franchise is the clearest offset.

Kubota occupies a different niche. It is a formidable compact-tractor and Asian-market competitor, with a broader Japanese industrial portfolio and far greater relevance in small agricultural equipment than AGCO's premium European core. Kubota is especially useful as a reminder of AGCO's weakness after the TAFE separation: the future of tractor-unit growth is disproportionately Asian, while AGCO has just relinquished its legacy Massey Ferguson identity in India. Kubota's 2026 filings continued to report agriculture as a major core operation.

Customers sort themselves accordingly. Farmers pick Deere when they want a deeply integrated machine-and-data system, very dense North American dealer support and strong residual values. They pick Fendt when premium tractor engineering, fuel efficiency and operator productivity justify the price. Massey Ferguson competes with a broader, more value-oriented proposition. Valtra has particular resonance in Nordic customization and South America. PTx appeals when a farmer wants productivity technology without standardizing the whole fleet on one OEM.

This suggests that the “open versus closed” precision-agriculture debate is not binary. Deere's closed strategy is rational for the market-share leader. AGCO's open strategy is rational for the challenger. The strategic mistake would be for AGCO to pretend that openness alone produces a software moat. Until subscriptions, connected services and recurring revenue become economically significant, PTx should be valued as differentiated agricultural technology with strong retrofit optionality, not as a farm SaaS platform.

Current fundamentals and the cycle-transformation split

Over the last four quarters AGCO has moved from deliberate inventory liquidation toward a hoped-for 2027 production recovery, but end demand has not yet turned convincingly.

Late 2025 was still a hard downcycle. Full-year sales fell to $10.08 billion, adjusted operating margin to 7.7% and adjusted EPS to $5.28. Yet working-capital release drove $740 million of free cash flow. Management entered 2026 expecting $10.4–10.7 billion of sales, a 7.5–8.0% adjusted operating margin and $5.50–6.00 of adjusted EPS.

Q1 initially appeared better. Derived from first-half and Q2 disclosures, Q1 sales were about $2.34 billion; adjusted EPS was around $0.94. AGCO raised its full-year adjusted EPS view toward approximately $6.00. The improvement partly reflected favorable currency, PTx comparison effects and cost actions, not an industry recovery.

Q2 then exposed the weakness underneath. Net sales were $2.61 billion, down 1.0% reported and about 3.7% excluding currency. GAAP EPS was $1.08 and adjusted EPS $1.43. Gross margin was about 24.7%; GAAP operating margin 5.4%, and adjusted operating margin approximately 6.6%. Replacement-parts sales were $516 million, up 3% reported and roughly flat in constant currency.

Management cut full-year revenue guidance to $10.1–10.2 billion and adjusted EPS to $5.50–5.75, with an adjusted operating margin around 7.5%. It guided Q3 sales to about $2.3–2.4 billion and adjusted EPS to only $0.85–0.90. The July revision effectively reversed Q1's increased earnings confidence. As of the September 21 research date, no Q3 2026 earnings report had been released.

The regional Q2 figures show why.

North America provided the growth, but Europe still provided the profit. Latin America was simultaneously shrinking and loss-making.

North American industry retail demand remained weak overall: first-half tractors excluding compact models were down around 9% and combines down about 7%. AGCO nevertheless grew regional sales nearly 20% in constant currency because of Fendt and Massey Ferguson high-horsepower tractor performance, hay equipment and favorable channel comparisons. That is encouraging market-share evidence. But the -5.2% segment margin shows that revenue growth without normalized factory absorption and mix does not automatically create attractive economics.

Western Europe is the pivotal variable. First-half industry tractor registrations were still up roughly 3%, but Q2 weakened, and Germany deteriorated more than AGCO had expected. Management said it gained share in Germany but lost some in France. Because dealer inventories were only about 3.5 months versus a four-month target, the most defensible interpretation is that retail demand softened after inventories had already been cleared. A restocking bounce alone cannot repair that.

Earnings sensitivity here is large. If EME annual sales around the 2025 level of $6.74 billion were to fall another 10%, and the decremental operating margin on the lost volume were 25–30%, group EBIT would decline roughly $170–200 million. After a 25% tax assumption and using roughly 70 million shares, that is around $1.80–2.15 per share of earnings. This is my sensitivity calculation, not company guidance. It explains why a prolonged German/French slump can overwhelm much of management's planned cost reduction.

Latin America looks more like a conventional inventory correction. Brazil first-half tractor industry demand was down about 11% and combine demand down around 39%. AGCO's Latin American inventory remained about half a month above target. Management cut production by roughly 30% in Q2 to clear aged combines, sprayers and planters. Once that stock is gone, 2027 production can rebound even if retail demand merely stops falling.

North America sits between the two. Dealer units were down roughly 7%, and dealer inventory remained close to seven months versus a six-month goal. There is still a destocking headwind, but AGCO's own shipments and share gains show that Fendt and Massey Ferguson are taking some ground in selected categories. FarmerCore provides a plausible operational explanation, although it is too early to know whether the share gains survive a full recovery cycle.

Cycle-only normalization can be estimated without assuming the transformation succeeds. Start with 2026 sales near $10.15 billion and management's statement that global equipment demand is around 85% of mid-cycle. Applying a full 17.6% uplift to all revenue would be too aggressive, because parts and some precision revenue are less cyclical. A more conservative normalization puts sales around $11.4–11.8 billion before giving substantial incremental credit to PTx or strategic parts growth. With factory absorption normalized but without assuming management reaches a 14–15% margin, I use roughly 10.5–11.5% adjusted operating margin for the cycle-only business.

The transformation then sits on top.

The first column is company guidance/current disclosure; later columns are my research scenarios. The $2 billion PTx and $2.3 billion parts figures are management's 2029 ambitions, not forecasts.

This separation is essential. A return from 85% to normal industry demand can create a large earnings recovery even if AGCO has not become structurally better. Investors should not credit that cyclical operating leverage to PTx. Conversely, if normalized operating margin eventually settles around 12% instead of falling back toward historical trough levels, then the transformation has genuinely lifted the earnings floor.

PTx is the hardest part to underwrite. Its 2025 revenue of approximately $860 million included AGCO factory business, third-party OEM relationships and aftermarket retrofit. AGCO does not disclose the revenue split among those routes. Nor does it publish PTx operating profit. Claims that PTx already earns a materially higher group margin cannot be independently quantified.

What can be verified is distribution and product cadence. AGCO introduced 14 PTx products across the crop cycle during 2025 and planned another dozen in 2026. The Elite dealer count rose from fewer than 35 at the beginning of 2025 to more than 70 at year-end and around 85 by mid-2026. Total PTx dealer relationships were around 320. That infrastructure can support much higher sales without requiring AGCO to win corresponding machine share.

Target math is still demanding: the $860 million 2025 base must compound 23.5% annually to hit $2 billion in 2029. If 2026 is merely flat at roughly $860–900 million, the required 2027–29 CAGR rises toward 30% or more. A business that is supposed to provide structural growth should eventually grow through an equipment trough; “retrofit held up better than the market” is useful evidence, but flat total PTx revenue in 2026 falls short of the growth implied by the public target.

Nothing in this story is more over-interpreted than the software component. AGCO recognizes some precision services and subscription revenue over time, but the annual report explicitly says those revenues are not significant. Most PTx economics are still tied to hardware shipments and technology-equipped machinery. That can be a good business. It simply deserves a machinery-technology multiple until recurring economics become material.

Parts have a better burden of proof. The move from $1.87 billion in 2025 to $2.3 billion in 2029 requires only around 5.3% annual growth. Installed-base aging, e-commerce, better availability and FarmerCore can plausibly deliver that even without a dramatic global equipment boom. Parts also dampen cyclicality, because older fleets require more maintenance precisely when farmers defer new machines.

Exiting Grain & Protein reinforces the same mix shift. Reported 2024 sales included $816.5 million from the divested business; 2025 residual Grain & Protein sales were only around $1 million. Comparing $14.4 billion of 2023 revenue with a $10.1 billion 2026 run rate therefore exaggerates the like-for-like collapse. Some of the missing revenue was deliberately sold. The correct investment question is whether the remaining revenue base earns more across a cycle, not whether AGCO returns to the old consolidated peak mechanically.

The TAFE settlement has the opposite long-run mix implication. It produced $230 million of after-tax cash and removed a contentious minority investment, but AGCO relinquished the Massey Ferguson brand in India, Nepal and Bhutan. That is a real opportunity cost, because lower-horsepower tractor growth is increasingly Asian. AGCO retains the ability to pursue other brands and PTx technology, and its agreement includes certain rights around future brand transactions, so the transfer should not be characterized as a legal exit from India. It does remove the most obvious and historically established route.

On governance, the shareholder standstill mitigates immediate risk. The proxy language is stronger than the task brief suggested: the standstill does not have a scheduled expiry. TAFE's restrictions can change upon specified change-of-control and tender-offer events, but there is no ordinary date on which TAFE automatically becomes free to resume activism. For ordinary shareholders that is stabilizing while current strategy executes. The latent conflict remains because a direct competitor owns a large block and could become strategically important if AGCO itself enters a control transaction.

Capital returns have become substantial enough to affect the thesis. AGCO's board authorized a $1 billion repurchase program without a stated expiry in July 2025. The company executed a $250 million accelerated repurchase late that year and spent about $347 million on repurchases in the first half of 2026. The shrinking share count improves per-share recovery economics, but the opportunity cost is debt reduction. With net debt still above $2 billion and PTx's economic return unproven, a balanced capital-allocation policy should not allow buybacks to outrun free cash flow for long.

Farm economics point to a trough, not a clear rebound. Farmers are receiving support payments and benefit from lower machinery prices in some categories, but low crop returns, financing costs, fertilizer and fuel pressure remain obstacles. The machinery order book is a lagging signal: I model roughly two to four quarters between a sustained improvement in farmer economics and stronger large-equipment orders, followed by additional lag as dealers decide whether to rebuild inventory. That lag is an analytical assumption, not a company statistic.

For the next 12 months, the implication is that AGCO can produce earnings upside before end-market units fully recover if channel inventories normalize and factories stop underproducing retail. The 3–5-year outcome requires more: PTx must reaccelerate, Fendt must continue gaining outside Europe, and the group must retain a materially higher margin at the next trough.

Valuation, risks and catalysts

The cash-flow passthrough should come before the multiple.

AGCO's five-year cash record is noisy because working capital swings by hundreds of millions of dollars. Across the cycle, operating cash flow has broadly covered adjusted earnings; in 2025 it substantially exceeded them because inventory liquidation released cash, while H1 2026 cash flow swung negative as working capital rebuilt. The right owner-earnings measure normalizes working capital instead of capitalizing either extreme.

AGCO does not disclose maintenance versus growth capex. I estimate maintenance capital expenditure at roughly $240–270 million annually, anchored by the $248 million spent in the deep 2025 downturn while the global manufacturing system continued operating. Against 2026 capex guidance of $300–325 million, that implies roughly $50–80 million of discretionary/growth capital. This is an assumption, not company guidance.

At the midpoint of 2026 adjusted EPS guidance and an approximate 70.5 million weighted share base, adjusted net income is around $397 million. Management's 75–100% FCF conversion target then implies about $300–400 million of reported free cash flow. Adding back an estimated $50–80 million of growth capex produces a rough owner-earnings range of $350–480 million, or about $5–6.8 per current share. At $119.79 that is a 4.2–5.7% owner-earnings yield, equivalent to roughly 18–24 times trough owner earnings. The gap versus the 21.3 times adjusted EPS multiple is below 30%, so there is no reason to abandon earnings-based valuation; both measures say the same thing: the current year is not cheap on trough economics.

On 2025 numbers the FCF yield looks much better: $740 million divided by the present equity value is nearly 9%. That should not be used as a permanent yield, because much of the cash came from working-capital release. Using H1 2026 negative FCF as a permanent run rate would be equally wrong.

Peer valuation also needs cycle adjustment. Deere's current market capitalization and earnings multiple are far higher than AGCO's, but Deere's denominator is also depressed by the machinery cycle and its consolidated group includes construction and financial services. CNH likewise has accounting and cycle effects that make a one-year P/E a poor ranking tool. The proper read-through is that the market awards Deere a substantial quality premium for its installed base, dealer economics, precision integration, captive finance and capital returns; AGCO must earn any narrowing of that gap.

AGCO's current reported trailing P/E from market-data services is roughly 16–17 times, but that metric is especially misleading because trailing GAAP earnings include the TAFE sale gain and other one-time tax/portfolio items. 2025 GAAP EPS of $9.75 was far above adjusted EPS of $5.28, while 2024 GAAP EPS was negative because of the Grain & Protein disposal loss, PTx goodwill impairment and restructuring. The adjusted and normalized numbers are the relevant valuation bases.

The scenario analysis below separates cyclical normalization from structural success.

These are valuation scenarios within a research framework, not investment advice. Company targets used as inputs are disclosed separately from my assumptions.

The conservative case assumes this is fundamentally still a conventional cyclical. Demand improves somewhat from trough, but Europe remains soft, PTx never approaches $2 billion, and the margin settles at only 9–10%. An $8–9 EPS business at an 11–12 times cycle multiple is worth roughly $95–105. This is not a bankruptcy case; it is a “transformation disappoints” case.

The base case gives AGCO credit for the cycle and some, but not all, of management's structural objectives. Equipment demand returns toward normal, parts approaches roughly $2.2 billion, PTx reaches $1.4–1.7 billion instead of $2 billion, cost actions persist, and adjusted operating margin normalizes around 12%. That supports roughly $12–13.5 of adjusted EPS. A 10–10.5 times normalized multiple gives an anchor near $132.

The optimistic case requires AGCO to prove that management's mid-cycle margin framework is real. Precision agriculture reaches around $2 billion, parts reaches around $2.3 billion, Fendt share gains continue, and the company earns 14–15% adjusted operating margin without another commodity supercycle. Even then I use only a roughly 10 times normalized P/E, because agricultural machinery remains cyclical. That produces a fair-value anchor around $165 rather than a technology-style valuation.

Holding the multiple down is intentional. Peak cyclical earnings normally deserve a lower P/E than trough earnings. Applying a 20 times multiple to $16 of normalized machinery EPS would double-count the recovery and the transformation.

Historical valuation does not supply a cleaner answer. AGCO's apparent P/E rises automatically at trough and compresses at peak. On 2026 earnings the stock sits in the expensive half of a normal cyclical framework; on $12–13 normalized earnings it sits close to a conventional 10 times mid-cycle valuation. A precise percentile would convey false precision without a fully restated decade of adjusted EPS and EV/EBITDA.

What the market expects at $119.79 is identifiable. Investors are already pricing a significant cyclical earnings rebound from $5.50–5.75, because $120 would be an unusually rich permanent valuation for a $5–6 farm-machinery EPS stream. They are not pricing full management success, because a credible $15–17 through-cycle EPS base would make the present stock inexpensive even at a single-digit/low-double-digit multiple.

The next expectation gap is likely to come from four numbers: Western European retail demand, dealer inventory, PTx growth and the adjusted margin bridge. A sales beat created only by favorable currency is low quality. A sales beat accompanied by Europe remaining near 3.5 months of inventory and improving registrations would be much more important. PTx returning to double-digit organic growth would validate the structural thesis; another flat year would make the $2 billion commitment increasingly difficult to defend.

The independent margin-of-safety test is less flattering than the normalized P/E.

Current price is roughly 20% above the $100 conservative fair-value anchor. By the framework in this report, the margin of safety against the conservative case is therefore zero.

Structural margin improvement, not volume normalization, is the most fragile base-case assumption. I attribute roughly $15–20 per share of the $132 base value to PTx/parts/cost actions beyond an ordinary machinery recovery. If only 70% of that incremental value is realized, the base fair-value estimate falls to roughly $125–127. That leaves little upside from $119.79.

A three-year “no earnings growth” case is worse. If per-share earnings and the valuation multiple are unchanged, shareholder return is essentially the dividend yield, around 1% using the recent annual dividend level. That is below the return available from long-duration U.S. government debt during the current rate environment. Under the discipline this report applies, there is no margin of safety at this buy price in the flat-earnings case.

This is not a simple “good company, bad price” setup, because AGCO's quality itself is still being upgraded rather than proven. The price is reasonable for a successful normalization but offers inadequate protection if Europe remains weak and PTx underdelivers.

Margin-of-safety sufficiency verdict: none.

The largest permanent-loss risk is prolonged European weakness. I assess the probability as medium and the impact as high. The observable indicators are German and French tractor registrations, EME sales, EME margin and dealer months of supply. Because dealer stock is already below target, another 10% regional sales decline would travel rapidly through factory utilization into EBIT. My sensitivity suggests $1.80–2.15 of annual EPS could disappear before compensating cost action. That would also puncture the narrative that current earnings represent a trough.

The second is PTx economic disappointment, medium probability and high impact. The first warning indicator is revenue growth below about 15% during 2027; the second is any retreat from the $2 billion 2029 target; the third is another material impairment. The transmission path is broader than the lost sales. A PTx miss would invalidate part of the argument for a permanently higher margin and could compress AGCO's normalized valuation multiple at the same time. The 2024 $351 million goodwill impairment proves that this risk is not theoretical.

The third is channel normalization taking longer than expected. Probability is medium and impact medium-high. North America remains near seven months of dealer inventory against a six-month target, and Latin America around 3.5 versus three. If those numbers do not fall, AGCO must continue producing below retail, suppressing factory absorption even if farmer demand stops deteriorating. The flip side: reaching target quickly is one of the cleanest 2027 earnings catalysts.

The fourth is balance-sheet and cash-conversion risk. Probability is low-to-medium, impact medium. Net debt around $2.15 billion is manageable, but H1 2026 free cash flow was negative roughly $347 million and the company has simultaneously been repurchasing shares. The key indicator is full-year FCF conversion. A result materially below the 75% lower bound, combined with continued buybacks and no earnings recovery, would indicate that capital returns are outrunning internally generated cash.

The fifth is tariff, currency and farm-credit pressure. Probability is medium and impact medium. AGCO already expects roughly $95 million of net tariff cost in 2026. A stronger dollar would also reverse the favorable translation effect that has helped 2026 reported sales, while delayed Brazil financing can push orders across fiscal periods. The observable indicators are pricing versus tariff inflation, constant-currency growth and Brazil's dealer inventory.

TAFE is now a lower-probability governance risk than the 2024 public dispute suggested. The perpetual standstill materially reduces ordinary activism risk. Impact could become high in a takeover or control contest, because specified transactions can alter TAFE's restrictions. The ordinary operating risk is instead strategic: AGCO must find another way to participate in Indian growth after transferring the Massey Ferguson brand.

Positive catalysts over the next 12–24 months are concrete. European retail registrations could stabilize while inventories are below target, producing immediate wholesale restocking. Latin American inventory could fall toward three months, allowing 2027 factory production to rise even on flat retail. PTx could return to double-digit growth as SymphonyVision and other 2025–26 launches scale. Cost savings could push the adjusted margin above 8% before a broad volume recovery. And continued buybacks at trough valuations could materially increase per-share normalized earnings.

Negative catalysts are equally observable: another 2026 guidance cut, EME margins moving into the low teens, PTx staying flat into 2027, North American dealer inventory remaining around seven months, failure to reach 75% full-year cash conversion, or Brazil financing continuing to delay retail purchases.

The dashboard below tracks those variables, not daily share-price noise.

The final row is a research estimate for the expected late-October reporting window; as of September 21 AGCO's investor-relations page had not posted a confirmed Q3 earnings date, so 2026-10-29E should not be read as a company-announced date.

Cross-synthesis, final research conclusion, uncertainties and sources

Vertically, AGCO has proven one capability beyond doubt: it knows how to assemble and preserve agricultural brands whose commercial lives are much longer than normal industrial product cycles. Massey Ferguson, Fendt and Valtra came from different corporate histories, geographies and customer bases, yet AGCO kept them economically relevant inside one manufacturing and distribution group. That is harder than it looks. Many roll-ups destroy the local identities they buy; AGCO's premium German brand became more valuable under the group, not less.

The second proven capability is operating through agricultural cycles. The company has survived several sharp equipment downturns and understands the basic mechanics of underproducing retail to clean dealers, releasing working capital, and then increasing production when inventories normalize. Record 2025 free cash flow during a severe earnings contraction is good evidence that today's management team can execute that playbook. The current North American and Latin American production cuts fit the same pattern.

A third capability is only partly proven: repositioning the portfolio toward better businesses. Precision Planting was strategically farsighted, because it gave AGCO a credible technology entry point without requiring corresponding machine share. Exiting Grain & Protein sharpened the portfolio. Parts growth is real and measurable. FarmerCore addresses an actual historic weakness in North American dealer reach. These are more than slogans.

The PTx Trimble purchase is the missing proof point. Management bought a large technology asset for almost $2 billion just as the farm cycle rolled over and then impaired roughly $351 million of goodwill. The subsequent 2025 revenue base of about $860 million is meaningful, and customer/dealer penetration is expanding, but the business now needs to grow roughly 23.5% annually from 2025 through 2029 to meet the public revenue objective. Flat-to-modest growth in 2026 consumes one quarter of the available time.

So the company's fate depends unusually heavily on whether a cyclical recovery and structural transformation arrive in the right order. If the cycle recovers first, higher factory utilization will produce an EPS rebound and give PTx time to mature. If Europe remains depressed while management simultaneously has to spend on PTx distribution, engineering and product launches, investors may discover that the transformation costs arrive before the benefits.

Horizontally, AGCO's competitive advantage is more specific than “technology.” Deere has greater scale, a deeper installed base, superior North American channel density and a mature integrated precision ecosystem. CNH has broad full-line equipment scale and a stronger combine position. Kubota has much better exposure to compact equipment and Asia. AGCO's advantage sits at the intersection of Fendt's premium product economics, a large global tractor installed base and an unusually open retrofit precision strategy.

This is exactly why AGCO's mixed-fleet strategy is strategically rational. The company cannot win by requiring every PTx customer to replace a Deere or Case machine with Fendt first. It can win by putting productivity technology on that Deere or Case machine and then using dealer relationships to expand its share of the farm's wallet. Openness turns AGCO's smaller installed base from an absolute constraint into a less binding one.

Value capture is where that model is weak. Deere can potentially make machine hardware, software, data, service and finance reinforce one another. AGCO may win a PTx hardware sale while Deere still owns the tractor relationship, financing relationship, telemetry history and replacement decision. AGCO needs recurring services or demonstrably superior retrofit economics to compensate. Which is why the annual report's disclosure that subscription revenue remains insignificant is one of the most important pieces of evidence in the entire report.

The market is probably correctly pricing the ordinary cycle and only partly pricing the transformation. At $119.79, paying about 21 times trough adjusted EPS would make little sense if investors believed $5–6 was permanent earning power. The shares implicitly assume recovery. Against that, the price is only around 9–10 times my $12–13.5 transformed-base normalized EPS estimate. Full execution of 14–15% margins and $2 billion PTx sales is clearly not in the price.

The most likely market misjudgment is subtler: investors may be treating all eventual EPS recovery as evidence that AGCO's business quality improved. A 2027 restocking cycle could lift margins and EPS sharply even if PTx misses its target and Europe merely returns to normal. Distinguishing cyclical operating leverage from structural margin improvement will matter more than the headline EPS number.

For the next year, dealer inventories and Western Europe dominate. Europe at 3.5 months of inventory against a four-month target tells us that inventory liquidation has largely finished there. A recovery in German and French farmer confidence would flow into AGCO orders quickly. Continued retail deterioration would hit the highest-margin geography with little channel buffer.

For the next three years, the decisive variable is PTx growth. By 2027 the company can no longer plausibly explain low PTx growth as a one-year machinery trough if the 2029 target remains intact. A 15–20% or better growth rate, rising Elite dealer productivity and early recurring-revenue evidence would materially improve the thesis. Growth below 10–15% would make $2 billion increasingly aspirational.

For the next five years, the relevant question is the margin floor. AGCO's stated mid-cycle ambition of roughly 14–15% adjusted operating margin is far above the 7.5% expected in 2026. If the next ordinary downcycle bottoms at 8–10% instead of the much lower margins of earlier cycles, then Fendt, parts, precision and cost discipline genuinely changed the business, and that would justify a structurally higher normalized valuation. If the next trough looks like the old ones, the technology narrative will have proved secondary.

Capital allocation can improve the outcome but cannot manufacture it. A 6% endpoint share-count reduction is meaningful. Buying back shares below normalized intrinsic value compounds recovery for remaining owners. Buying back shares while free cash flow misses guidance and leverage stays elevated would simply transfer balance-sheet optionality into EPS optics. The company should continue to treat deleveraging and technology returns as peers of buybacks, not subordinates.

TAFE is unlikely to be the proximate driver of the stock. The settlement converted an awkward minority investment to cash, settled a public dispute and locked the shareholder into an indefinite standstill. The cost is strategic rather than near term: AGCO no longer owns Massey Ferguson in India, Nepal and Bhutan. The next five years will reveal whether PTx or other AGCO brands can establish an Indian route without the old TAFE architecture.

The pure-play case is clean. An AGCO shareholder gets unusually concentrated exposure to a global agricultural-equipment recovery, Fendt share gains, parts monetization and PTx adoption. Deere dilutes that exposure through construction and finance; Kubota dilutes it through different equipment and geographic mixes. Concentration is attractive when the farm cycle rises and a liability when Europe, Brazil and global crop economics weaken simultaneously.

Bull reasons:

• Europe generated about two-thirds of 2025 sales and a 14.9% segment margin, while dealer inventory is already below target, so even modest retail stabilization can convert rapidly into wholesale and factory recovery.
• PTx already has about $860 million of revenue, more than 100 third-party OEM relationships, roughly 320 dealers and a retrofit route that addresses competitors' installed fleets.
• Replacement parts reached $1.87 billion and 19% of 2025 sales, creating a more resilient earnings stream with only about 5% annual growth required to reach the 2029 target.
• Dealer destocking is advanced enough that North American and Latin American production can eventually rise faster than retail, giving AGCO significant operating leverage during normalization.

Bear reasons:

• Western European weakness increasingly reflects end demand because dealer inventory is already below management's normal level, exposing AGCO's highest-margin geography to further negative operating leverage.
• PTx's $2 billion target requires about 23.5% annual growth from 2025, yet management expects only flat-to-modest 2026 growth and subscription revenue remains insignificant.
• AGCO impaired approximately $351 million of PTx Trimble goodwill in 2024, showing that management's original technology-acquisition economics were too optimistic almost immediately.
• Current price is about 21 times trough adjusted EPS and stands roughly 20% above the conservative valuation anchor, so a failed recovery has meaningful downside despite the apparently low normalized P/E.

Pre-mortem script one: Europe fails to recover through 2027. German and French tractor demand falls another 10%, EME revenue drops around $650–700 million and EME margin compresses from roughly 15% toward 10–11% as Fendt factories lose absorption. Group adjusted EPS remains around $6–7 instead of recovering above $10. Investors stop treating 2026 as the trough and assign 10–11 times earnings. A $60–75 share price becomes plausible, a decline of roughly 40–50% from the base-date price.

Pre-mortem script two: the machinery cycle recovers but PTx does not. In 2027 Deere, CNH/Raven and independent precision providers keep enough competitive pressure on retrofit hardware that PTx grows less than 10%, and AGCO withdraws or substantially reduces the $2 billion target. Recurring revenue remains immaterial, another impairment follows, and normalized operating margin settles near 9–10% instead of 12–15%. At $8–9 normalized EPS and a roughly 9–10 times multiple, the stock trades around $70–90 despite healthier farm-equipment volumes. This would be the clearest evidence that AGCO remained a conventional cyclical with a technology narrative attached.

The final research judgment follows from the asymmetry. AGCO is a materially better portfolio than it was several years ago: Grain & Protein is largely gone, parts are a larger share, Fendt is expanding geographically, FarmerCore attacks a dealer weakness, and PTx creates access to competitors' fleets. The downcycle also looks mature enough that inventory normalization can eventually produce strong operating leverage.

The evidence is not strong enough to pay aggressively for the transformation. Europe is weakening with inventories already lean. PTx is tracking far below the growth rate implied by 2029 if 2026 remains flat. Precision subscriptions are not yet material, and the acquisition has already produced a large goodwill impairment. At $119.79 the stock offers reasonable exposure to a recovery but little conservative margin of safety.

【Company-profile scores】

• Fundamental quality: medium
• Growth: medium
• Moat: medium
• Financial soundness: medium
• Management credibility: medium
• Valuation attractiveness: medium
• Risk level: high
• Suitable investor type: cyclical

【Investment rating】

• Rating: Hold
• One-line thesis: AGCO prices in a meaningful cycle recovery while PTx's 2029 growth requirement remains unproven and Europe's high-margin market is weakening.
• Ideal buy price: see the required line below.
• Acceptable hold price: 112–152 USD
• Clearly overvalued price: 182–200 USD
• Current-price classification: acceptable hold
• Whether to wait for a better price: yes. For new capital, I would wait for the 75–80 USD ideal-buy range, or for enough fundamental evidence to raise the conservative earnings floor materially. The opportunity cost is missing an early 2027 dealer-restocking rally.
• Target holding horizon: 3–5 years
• Expected annualized return: approximately -5% conservative, 4% base and 12% optimistic, assuming three-year convergence toward the scenario anchors plus roughly the recent annual dividend run rate.
• Max-loss risk: roughly 45–55% in the pre-mortem combination of prolonged European weakness and PTx failure, taking the shares toward roughly $55–70.
• Reassessment-trigger signals: EME margin below 11% for two consecutive quarters; PTx 2027 growth below roughly 15% or withdrawal of the $2 billion target; North American dealer inventory remaining at or above seven months through 2027; full-year FCF conversion below 75%; or a new material PTx impairment.

【Ideal Buy Price】75–80 USD

Basis: at least about 20% below the roughly $100 conservative fair-value anchor, leaving room for Europe to remain weak and for the PTx target to be materially missed.

【Valuation Range】

• current: 119.79 (close as of 2026-09-18)
• bear (conservative · ideal buy zone): [75, 80]
• base (fair · acceptable hold zone): [112, 152]
• bull (optimistic · above the clearly-overvalued line): [182, 200]

The range deliberately contains gaps. A price between $80 and $112 would be increasingly attractive but would not yet meet the report's strict 20%-below-conservative-value definition of an “ideal” entry. A price between $152 and $182 would be expensive but not yet more than 10% above the optimistic fair-value anchor.

Research uncertainties are concentrated in five areas. First, AGCO does not disclose PTx operating margin, factory-fit/OEM/retrofit revenue mix or significant recurring-revenue detail, so the most important structural business lacks a stand-alone P&L. Second, Fendt's brand margin and order book are not separately reported, forcing regional EME profitability and dealer inventory to serve as proxies. Third, the historical IPO date and $14 offer price are verified, but I did not obtain a sufficiently reliable primary archival figure for the original gross proceeds and therefore do not invent one. Fourth, a clean same-date primary corn/soybean/wheat price panel was not fully available in the research extract; soybean and farm-income data are used directionally, not to build a spurious farm-income regression. Fifth, AGCO had not announced an exact Q3 2026 reporting date on its IR calendar by the base date, so the dashboard's October 29 date is an estimate, not a company commitment.

Primary research sources included AGCO's 2025 Form 10-K and 2026 second-quarter Form 10-Q; the February 5, May 5 and July 30, 2026 earnings materials; the July 2026 earnings-call transcript; the 2026 proxy statement; the Grain & Protein sale documents; Trimble's filing on its retained PTx interest; and AGCO's investor-relations trading/IPO information.

Industry cross-checks included Deere's latest 2026 results, CNH's second-quarter disclosure, Kubota's first-half 2026 release, USDA farm-income/WASDE information and Copernicus weather data. Those sources were used to test AGCO management's cycle narrative rather than to substitute third-party estimates for AGCO's own reported numbers.

Other tickers mentioned

• DE.US: Deere is the key benchmark for high-horsepower agriculture, integrated precision technology, dealer economics and captive finance.
• CNH.US: CNH Industrial is AGCO's closest listed structural agricultural-equipment comparable through Case IH, New Holland and Raven.
• TRMB.US: Trimble retains a 15% economic interest in PTx Trimble and provides an independent accounting cross-check on the joint venture.
• 6326.TSE: Kubota is the principal listed comparison for compact tractors, small agriculture and Asian market exposure.
• 601038.SHG: First Tractor is a listed Chinese tractor manufacturer relevant to Asian agricultural mechanization.
• 0038.HK: First Tractor's Hong Kong listing provides the same Chinese agricultural-machinery comparison.
• VMI.US: Valmont Industries is adjacent through irrigation and agricultural infrastructure but is not a direct machinery peer.
• TSCO.US: Tractor Supply is a U.S. rural-lifestyle retailer and a farm-economy demand indicator, not an agricultural-machinery competitor.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.